Clinical Trial Update: Efficacy Study to Evaluate B-Lock™ as an Antimicrobial Lock Solution in Dialysis Patients With a CVC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating B-Lock antimicrobial lock solution in dialysis patients with a central venous catheter was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dialysis Catheter Infections

Drugs mentioned

• B-Lock (antimicrobial lock solution)

Snippet

Sponsor: Great Lakes Pharmaceuticals Inc. | Conditions: Dialysis Catheter Infections | Phase 3 | Status: TERMINATED